These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Recurrent Membranous Nephropathy After Kidney Transplantation Associated With Phospholipase A2 Receptor and Successfully Treated With Rituximab: A Case Report. Ishiwatari A; Wakai S; Shirakawa H; Honda K Transplant Proc; 2018 Oct; 50(8):2565-2568. PubMed ID: 30316399 [TBL] [Abstract][Full Text] [Related]
8. Recurrence of anti-neutrophil cytoplasmic antibody vasculitis in the kidney allograft. Lau D; Summers S; Amos L; Simpson I; Mulley W Nephrology (Carlton); 2012 Apr; 17 Suppl 1():16-9. PubMed ID: 22497649 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?]. Busch M; Gerth J; Ott U; Schip A; Haufe CC; Gröne HJ; Wolf G Med Klin (Munich); 2008 Jul; 103(7):519-24. PubMed ID: 18604487 [TBL] [Abstract][Full Text] [Related]
10. Treatment of acute antibody-mediated rejection using bortezomib: a case report. Sin YH; Kim YJ; Oh JS; Lee JH; Kim SM; Kim JK Nephrology (Carlton); 2015 Jul; 20 Suppl 2():86-9. PubMed ID: 26031595 [TBL] [Abstract][Full Text] [Related]
11. Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy. Teisseyre M; Cremoni M; Boyer-Suavet S; Crepin T; Benzaken S; Zorzi K; Esnault V; Brglez V; Seitz-Polski B Front Immunol; 2021; 12():738788. PubMed ID: 34721403 [TBL] [Abstract][Full Text] [Related]
12. [Efficiency of rituximab treatment for recurrence of membranous glomerulopathy after renal transplantation]. Wéclawiak H; Ribes D; Modesto A; Kamar N; Durand D; Rostaing L Nephrol Ther; 2007 Apr; 3(2):65-8. PubMed ID: 17452303 [TBL] [Abstract][Full Text] [Related]
13. Rituximab Administered for Recurrent Membranous Nephropathy in a Kidney Transplant Recipient Did Not Eliminate Donor-Specific Antibodies. Giannopoulou M; Tarassi K; Tsouka G; Christodoulidou C; Stefanidis I; Eleftheriadis T Exp Clin Transplant; 2022 Jul; 20(7):695-697. PubMed ID: 35924746 [TBL] [Abstract][Full Text] [Related]
14. Management of Membranous Nephropathy after MENTOR. Trivin-Avillach C; Beck LH Clin J Am Soc Nephrol; 2020 Mar; 15(3):415-417. PubMed ID: 31740571 [No Abstract] [Full Text] [Related]
15. Recurrent Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits in Kidney Allografts Treated With Anti-CD20 Antibodies. Buxeda A; Said SM; Nasr SH; Leung N; El Ters M; Cosio FG Transplantation; 2019 Jul; 103(7):1477-1485. PubMed ID: 30747850 [TBL] [Abstract][Full Text] [Related]
16. Beneficial effect of rituximab in the treatment of recurrent idiopathic membranous nephropathy after kidney transplantation. Sprangers B; Lefkowitz GI; Cohen SD; Stokes MB; Valeri A; Appel GB; Kunis CL Clin J Am Soc Nephrol; 2010 May; 5(5):790-7. PubMed ID: 20185599 [TBL] [Abstract][Full Text] [Related]